House Bill 6925
116th Congress(2019-2020)
Medical Innovation Acceleration Act of 2020
Introduced
Introduced in House on May 19, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
6925
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Medical Innovation Acceleration Act of 2020
This bill exempts non-invasive diagnostic devices from the regulatory authority of the Food and Drug Administration.
The bill defines non-invasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.
May 19, 2020
05/19/2020
Referred to the House Committee on Energy and Commerce.
05/19/2020
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:42:52 PM